跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,453 条关于
“Ananda Developments PLC”
全部
13,453
临床试验
6,952
药物
662
机构
1,939
资讯
3,900
去年
Ananda Developments Appoints Professor Marie Fallon to Scientific Advisory Board
去年
Ananda Developments Advances Cannabinoid Medicines in Phase III Epilepsy Trials
去年
Ananda Developments' MRX1 Achieves Key Stability Milestones, Advancing to Phase II Trials
去年
Ananda Developments' Cannabinoid Medicines to be Used in NHS Epilepsy Trials
去年
Ananda Developments Enters Phase III Trials for Cannabis-Based Epilepsy Treatment
去年
Ananda Developments' Cannabinoid Medicines to Undergo Phase III Trials for Refractory Epilepsy
去年
Ananda Developments Initiates Phase 1 Trial of CBD Compound MRX1 in Australia
9个月前
Ananda Pharma Exits Public Markets and NHS Epilepsy Trial to Focus on Pain Treatment Pipeline
3年前
hVIVO PLC Develops hMPV Human Challenge Model
去年
hVIVO Completes Pilot Study for Human Metapneumovirus (hMPV) Challenge Model
第 1 页,共 390 页
上一页
下一页